Impact of Blood Glucose Levels on in ICU Morbidity and Mortality in Patients With Acute Decompensated Heart Failure

NCT06453967 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2024-06-12

No results posted yet for this study

Summary

To evaluate the effect of blood glucose level at admission and glucose variability during ICU admission and their effect on in-hospital morbidity and mortality in patients admitted with acute decompensated heart failure

Conditions

Interventions

DIAGNOSTIC_TEST

blood glucose levels

measurement of blood glucose level at admission ,during ICU admission and at discharge for patients with acute decompensated heart failure

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ahmed Obeid Allah, Phd · Assiut University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-05-31
Completion
2025-09-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06453967 on ClinicalTrials.gov